Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DOI

10.1111/bjh.12985

Type

Journal article

Publication Date

01/11/2014

Volume

167

Pages

418 - 420

Total pages

2

Keywords

CALR, JAK inhibition, myeloproliferative disease, Anemia, Humans, Janus Kinase 1, Janus Kinase 2, Maximum Tolerated Dose, Nitriles, Primary Myelofibrosis, Protein Kinase Inhibitors, Pyrazoles, Pyrimidines, Recurrence, Splenomegaly, Symptom Assessment, Thrombocytopenia